搜索筛选:
搜索耗时4.3818秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
类      型:
[会议论文] 作者:Ping He,Changhua Zhou,Qing Li, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
  Objective: This study was undertaken to evaluate the selective activation and targeted cell killing of AKR1C3-prodrug both in vitro and in vivo for liver ca...
[会议论文] 作者:Ping He,Changhua Zhou,Qing Li, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
Objective: This study was undertaken to evaluate the selective activation and targeted cell killing of AKR1C3-prodrug both in vitro and in vivo for liver cancer cells....
[期刊论文] 作者:Hu Changhua,Zhou Zhijie,Zhang Jianxun,Si Xiaosheng,, 来源:Chinese Journal of Aeronautics 年份:2015
Once in the hands of end users, such durable equipment as spacecraft, aircraft, ships,automobiles, computers, etc. are in a state of debugging, working or stora...
[会议论文] 作者:Jianjun SUN,Gang GAO,Changhua ZHOU,Ya Liu,Ping JIANG, 来源:The 4th East Asian Symposium on Otology(第四届东亚耳科研讨会) 年份:2014
[会议论文] 作者:Jianjun SUN,Gang GAO,Changhua ZHOU,Ya Liu,Ping JIANG, 来源:The 4th East Asian Symposium on Otology(第四届东亚耳科研讨会) 年份:2014
Objective: To investigate the protective effects of antioxidant substances, edaravone, lipoic acid and the slow release dosage form-edaravone solid lipid nanoparticles (SLN), in steady noise-exposured...
[会议论文] 作者:YanFang Chen,ShaoRui Chen,ZhongBao Yue,YiQiang Zhang,ChangHua Zhou,WeiWei Cao,Xi Chen,LuanKun Zhang,PeiQing, 来源:2017年广东省药师周大会 年份:2016
Heart failure is associated with myocardial energy metabolic abnormality.Receptor-interacting protein 140(RIP140)is an important transcriptional cofactor for maintaining energy balance in high-oxygen...
[会议论文] 作者:Changhua Zhou,Meicun Yao,Siqi Chen,Qiang Huang,Qing Li,Bing Dong,Xiao Chen,Zhong Wang,Ning Zhang,Yawei, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
  Objective: As a potent angiogenesis inhibitor, Sunitinib has shown good response in clinic.However, severe toxic side effects limit its efficacy.To improve...
[会议论文] 作者:Changhua Zhou,Qiang Huang,Xiao Chen,Bing Dong,Siqi Chen,Ning Zhang,Yawei Liu,Anrong Li,Meicun Yao,Qing, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
Objective: As a potent angiogenesis inhibitor, Sunitinib has shown good response in clinic.However, severe toxic side effects limit its efficacy.To improve the therapeutic index of Sunitinib, an ester...
相关搜索: